These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9063961)

  • 41. Historical yearly usage of vancomycin.
    Kirst HA; Thompson DG; Nicas TI
    Antimicrob Agents Chemother; 1998 May; 42(5):1303-4. PubMed ID: 9593175
    [No Abstract]   [Full Text] [Related]  

  • 42. Therapeutic monitoring of vancomycin.
    Palmer-Toy DE
    Arch Pathol Lab Med; 2000 Feb; 124(2):322-3. PubMed ID: 10656750
    [No Abstract]   [Full Text] [Related]  

  • 43. Rationing antibiotic use in neonatal units.
    Isaacs D
    Arch Dis Child Fetal Neonatal Ed; 2000 Jan; 82(1):F1-2. PubMed ID: 10634830
    [No Abstract]   [Full Text] [Related]  

  • 44. CDC issues recommendations for preventing spread of vancomycin resistance.
    Am J Health Syst Pharm; 1995 Jun; 52(12):1272-4. PubMed ID: 7656113
    [No Abstract]   [Full Text] [Related]  

  • 45. Vancomycin use in pediatric cardiothoracic surgery patients.
    Shah SS; Sinkowitz-Cochran RL; Keyserling HL; Jarvis WR
    Pediatr Infect Dis J; 1999 Jun; 18(6):558-60. PubMed ID: 10391192
    [No Abstract]   [Full Text] [Related]  

  • 46. BSAC breakpoint recommendations.
    Wheat PF
    J Antimicrob Chemother; 1989 Jul; 24(1):79-81. PubMed ID: 2777731
    [No Abstract]   [Full Text] [Related]  

  • 47. Comment on: Vancomycin in adult prescribing: is it time to move on from trough-based dosing in the UK?
    Carson A; MacGowan A
    J Antimicrob Chemother; 2022 Jul; 77(8):2311-2312. PubMed ID: 35512320
    [No Abstract]   [Full Text] [Related]  

  • 48. Comment on: AUCs and 123s: a critical appraisal of vancomycin therapeutic drug monitoring in paediatrics.
    Avedissian SN; Le J; Neely MN; Cortés-Penfield N; Bradley J; Rybak MJ; Rhodes NJ
    J Antimicrob Chemother; 2021 Aug; 76(9):2486-2488. PubMed ID: 34021756
    [No Abstract]   [Full Text] [Related]  

  • 49. Farm-grown superbugs: while the world acts, Canada dawdles.
    Sibbald B
    CMAJ; 2012 Oct; 184(14):1553. PubMed ID: 22664761
    [No Abstract]   [Full Text] [Related]  

  • 50. Comment: monitoring vancomycin therapy.
    West RE
    Drug Intell Clin Pharm; 1987 May; 21(5):467. PubMed ID: 3582179
    [No Abstract]   [Full Text] [Related]  

  • 51. Comment: Vancomycin-resistant enterococci.
    Rapp RP
    Ann Pharmacother; 1996 Dec; 30(12):1500. PubMed ID: 9063961
    [No Abstract]   [Full Text] [Related]  

  • 52. Emerging resistance in Enterococcus spp.
    Heath CH; Blackmore TK; Gordon DL
    Med J Aust; 1996 Jan; 164(2):116-20. PubMed ID: 8569563
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Occurrence of vancomycin-resistant enterococci in relation to the administration of glycopeptide antibiotics.
    Kolár M; Vágnerová I; Látal T; Kohnová I
    Acta Univ Palacki Olomuc Fac Med; 1999; 142():69-71. PubMed ID: 10743728
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vancomycin-resistant enterococci and empirical vancomycin for CAPD peritonitis.
    Sandoe JA; Gokal R; Struthers JK
    Perit Dial Int; 1997; 17(6):617-8. PubMed ID: 9655168
    [No Abstract]   [Full Text] [Related]  

  • 55. [Vancomycin resistant enterococci in Austria].
    Allerberger F; Lass-Flörl C; Dierich MP; Hirschl AM; Presterl E; Haas G; Klare I; Witte W
    Wien Klin Wochenschr; 1997 May; 109(9):312-20. PubMed ID: 9265389
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.